直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Media Mention

Justice Department Will Not Challenge Benefits for Blue Water Navy Vets

June 5, 2019

The National Law Journal

The decision to allow “blue water” Navy veterans to be covered by the federal Agent Orange Act issued by the U.S. Court of Appeals for the Federal Circuit will not be challenged at the U.S. Supreme Court by the Justice Department. Previously, former service members who served on ships within the 12-mile territorial sea of the Republic of Vietnam had been denied the benefits and treatment related to Agent Orange exposure. The Justice Department and the Department of Veterans Affairs had claimed that the Act covered only those veterans who served on the ground or inland waterways of Vietnam. The Federal Court’s decision in January disagreed with that option and secured access to benefits for “blue water” veterans. Finnegan, along with veterans’ organizations, veterans’ legal services groups, and other major law firms, provided broad amicus support for the Navy veterans in both the Federal Circuit and the U.S. Supreme Court cases.

Tags

pro bono, United States Court of Appeals for the Federal Circuit (CAFC)

Related News

Award/Ranking

Forbes Names Finnegan Partner Erika Harmon Arner on its Inaugural 2026 America’s Top Women Lawyers List

June 5, 2026

Award/Ranking

Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked

May 28, 2026

Commentary

New Appellate Opinion in Amazon Biometric Data Case May Signal ‘Narrowing’ Scope of BIPA Litigation, Experts Say

May 20, 2026

Award/Ranking

Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award

May 13, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Award/Ranking

61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll

May 7, 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Announcement

Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International

May 4, 2026

Award/Ranking

Finnegan Wins IP Firm of the Year at the 2026 LSPN Awards

May 1, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP